Literature DB >> 19436943

Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy.

Masayuki Nakayama1, Ryuichi Iwakiri, Megumi Hara, Hibiki Ootani, Ryo Shimoda, Seiji Tsunada, Hiroyuki Sakata, Kazuma Fujimoto.   

Abstract

OBJECTIVE: This study aimed to clarify the current situation of bleeding peptic ulcers and examined the temporal changes in the pathogenic mechanisms requiring emergency endoscopy. PATIENTS AND METHODS: Study subjects were 285 bleeding peptic ulcer patients who received emergency endoscopy in Saga Medical School Hospital between 2000 and 2007. The ratios of H. pylori infection, NSAID use and low-dose aspirin use were analyzed for differences between the two periods by chi-square test. Logistic regression analysis was used to investigate factors such as patient characteristics that influenced the differences between each period.
RESULTS: A total of 221 (77.5%) patients were identified as H. pylori-positive. One hundred (35.1%) patients reported a history of NSAID use within 4 weeks. Among NSAID users, 41 patients received daily low-dose aspirin. One hundred forty-one patients had bleeding ulcers in 2000-2003 and 144 patients in 2004-2007. The odds ratio (OR) between the periods was 0.806 (95% CI, 0.461-1.409) for H. pylori infection and 1.590 (95% CI, 0.973-2.598) for NSAID usage. In contrast, the proportion of patients who took low-dose aspirin was 9.9% in the first period and 18.8% in the second period, and the difference was statistically significant (OR 2.093; 95% CI, 1.047-4.185). Logistic regression analysis revealed that cardiovascular disease and cerebral vascular disease were associated with aspirin use.
CONCLUSION: This study indicates that the causes of bleeding ulcers are changing, and the increasing use of low-dose aspirin might become a major cause of bleeding ulcers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19436943     DOI: 10.1007/s00535-009-0074-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  28 in total

1.  Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.

Authors:  M Takada; K Fukumoto; M Shibakawa
Journal:  J Clin Pharm Ther       Date:  2004-04       Impact factor: 2.512

Review 2.  Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.

Authors:  Angel Lanas; James Scheiman
Journal:  Curr Med Res Opin       Date:  2007-01       Impact factor: 2.580

Review 3.  Collaborative overview of randomised trials of antiplatelet therapy--II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-15

4.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

Review 5.  Helicobacter pylori.

Authors:  B J Marshall
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

6.  Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin.

Authors:  H T Sørensen; L Mellemkjaer; W J Blot; G L Nielsen; F H Steffensen; J K McLaughlin; J H Olsen
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

7.  Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.

Authors:  S Derry; Y K Loke
Journal:  BMJ       Date:  2000-11-11

8.  Trends in management and outcomes of acute nonvariceal upper gastrointestinal bleeding: 1993-2003.

Authors:  Laura E Targownik; Alice Nabalamba
Journal:  Clin Gastroenterol Hepatol       Date:  2006-11-13       Impact factor: 11.382

9.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.

Authors:  M R Griffin; J M Piper; J R Daugherty; M Snowden; W A Ray
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

10.  Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis.

Authors:  S E Gabriel; L Jaakkimainen; C Bombardier
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

View more
  15 in total

1.  Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes.

Authors:  Takahisa Furuta; Takayuki Iwaki; Kazuo Umemura
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

2.  Influence of low-dose proton pump inhibitors administered concomitantly or separately on the anti-platelet function of clopidogrel.

Authors:  Takahisa Furuta; Mitsushige Sugimoto; Chise Kodaira; Masafumi Nishino; Mihoko Yamade; Takahiro Uotani; Shu Sahara; Hitomi Ichikawa; Takuma Kagami; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Ken Sugimoto; Kazuo Umemura
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

3.  A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.

Authors:  Nobuyuki Sugisaki; Ryuichi Iwakiri; Nanae Tsuruoka; Yasuhisa Sakata; Ryo Shimoda; Shun Fujimoto; Yuichiro Eguchi; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2018-06-12       Impact factor: 7.527

Review 4.  Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.

Authors:  Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.

Authors:  Tsuyoshi Sanuki; Tsuyoshi Fujita; Hiromu Kutsumi; Takanobu Hayakumo; Shun-ichi Yoshida; Hideto Inokuchi; Manabu Murakami; Yoshihiro Matsubara; Hajime Kuwayama; Takashi Kawai; Hideki Miyaji; Takashi Fujisawa; Shuichi Terao; Yukinao Yamazaki; Takeshi Azuma
Journal:  J Gastroenterol       Date:  2012-04-17       Impact factor: 7.527

6.  Safety and Efficacy of Sedation During Emergency Endoscopy for Upper Gastrointestinal Bleeding: A Propensity Score Matching Analysis.

Authors:  Daisuke Yamaguchi; Goshi Nagatsuma; Yasuhisa Sakata; Yumi Mizuta; Tadahiro Nomura; Azuki Jinnouchi; Kasumi Gondo; Ryosuke Asahi; Satoshi Ishida; Shunichiro Kimura; Shun Fujimoto; Akane Shimakura; Amane Jubashi; Yuki Takeuchi; Kei Ikeda; Yuichiro Tanaka; Wataru Yoshioka; Naoyuki Hino; Tomohito Morisaki; Keisuke Ario; Seiji Tsunada; Motohiro Esaki
Journal:  Dig Dis Sci       Date:  2022-10-22       Impact factor: 3.487

7.  Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction.

Authors:  Ravi Vachhani; Doumit Bouhaidar; Alvin Zfass; Bimaljit Sandhu; Ali Nawras
Journal:  Ther Clin Risk Manag       Date:  2010-06-24       Impact factor: 2.423

8.  Evaluation of hemostasis with soft coagulation using endoscopic hemostatic forceps in comparison with metallic hemoclips for bleeding gastric ulcers: a prospective, randomized trial.

Authors:  Seiichiro Arima; Yasuhisa Sakata; Shinichi Ogata; Naoyuki Tominaga; Nanae Tsuruoka; Kotaro Mannen; Ryosuke Shiraishi; Ryo Shimoda; Seiji Tsunada; Hiroyuki Sakata; Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-12-25       Impact factor: 7.527

9.  Time trends in incidence of peptic ulcer bleeding and associated risk factors in Norway 1985-2008.

Authors:  Kåre E Bakkevold
Journal:  Clin Exp Gastroenterol       Date:  2010-06-29

10.  Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.

Authors:  Kentaro Sugano; Yasushi Matsumoto; Tsukasa Itabashi; Sumihisa Abe; Nobuhiro Sakaki; Kiyoshi Ashida; Yuji Mizokami; Tsutomu Chiba; Shigeyuki Matsui; Tatsuya Kanto; Kazuyuki Shimada; Shinichiro Uchiyama; Naomi Uemura; Naoki Hiramatsu
Journal:  J Gastroenterol       Date:  2011-04-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.